Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Concurrent daily cisplatin and extended-field radiation therapy for carcinoma of the cervix.

Concurrent daily cisplatin and extended-field radiation therapy for carcinoma of the cervix. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Concurrent daily cisplatin and extended-field radiation therapy for carcinoma of the cervix. Abstract Text:

    t unoT Uno,a mitsuhashiA Mitsuhashi,k isobeK Isobe,s yamamotoS Yamamoto,h kawakamiH Kawakami,n uenoN Ueno,h usuiH Usui,s tateS Tate,t kawataT Kawata,h itoH Ito,t unoT Uno,a mitsuhashiA Mitsuhashi,k isobeK Isobe,s yamamotoS Yamamoto,h kawakamiH Kawakami,n uenoN Ueno,h usuiH Usui,s tateS Tate,t kawataT Kawata,h itoH Ito,t unoT Uno,a mitsuhashiA Mitsuhashi,k isobeK Isobe,s yamamotoS Yamamoto,h kawakamiH Kawakami,n uenoN Ueno,h usuiH Usui,s tateS Tate,t kawataT Kawata,h itoH Ito,

    The aim of this study was to assess acute toxicities of concurrent low-dose daily cisplatin and extended-field radiation therapy (EFRT) for carcinoma of the uterine cervix. Fifteen women with cervical cancer who were treated with concurrent daily low-dose cisplatin and EFRT were analyzed. Daily cisplatin dose was fixed to 8 mg/m(2), which was determined in the preceding phase I study using pelvic radiotherapy. Twelve patients underwent either combined external beam radiation therapy and intracavitary brachytherapy or external beam radiation therapy alone. Three other patients were treated with adjuvant chemoradiotherapy after surgery. A total dose of EFRT ranged from 40 to 45 Gy, with an additional boost to the gross tumor volume up to 50.4-55 Gy. A median total dose of cisplatin during entire radiation therapy course was 224 mg/m(2) (range, 200-240 mg/m(2)). In 14 of 15 patients (93%), daily cisplatin could be delivered continuously as planned without any modification. Administration of cisplatin had to be interrupted in only one patient for only 3 days. Fourteen patients developed grade 2 or worse leukopenia including five after treatment, grade 2 in four, grade 3 in eight, and grade 4 in two. Grade 3 thrombocytopenia was observed in three patients. Grade 2 or worse anemia was observed in 12. Three patients had grade 3 nonhematologic toxicities, diarrhea in two, and nausea/vomiting in one. Although moderate to severe hematologic toxicities are common, this study suggests that concurrent low-dose daily cisplatin and EFRT are feasible. A cumulative cisplatin dose of greater than 200 mg/m(2) during radiation therapy could be achieved by using daily cisplatin dose of 8 mg/m(2).

    Concurrent daily cisplatin and extended-field radiation therapy for carcinoma of the cervix. Publishing Authors By Initials

    t unoT Uno,a mitsuhashiA Mitsuhashi,k isobeK Isobe,s yamamotoS Yamamoto,h kawakamiH Kawakami,n uenoN Ueno,h usuiH Usui,s tateS Tate,t kawataT Kawata,h itoH Ito,t unoT Uno,a mitsuhashiA Mitsuhashi,k isobeK Isobe,s yamamotoS Yamamoto,h kawakamiH Kawakami,n uenoN Ueno,h usuiH Usui,s tateS Tate,t kawataT Kawata,h itoH Ito,t unoT Uno,a mitsuhashiA Mitsuhashi,k isobeK Isobe,s yamamotoS Yamamoto,h kawakamiH Kawakami,n uenoN Ueno,h usuiH Usui,s tateS Tate,t kawataT Kawata,h itoH Ito,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE: 2008 Jan-Feb

    Concurrent daily cisplatin and extended-field radiation therapy for carcinoma of the cervix. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: International journal of gynecological cancer : of

    VOLUME: 18

    Page Numbers: 80-4

    Journal Abbreviation: Int. J. Gynecol. Cancer

    ISSN: 1048-891X

    DAY: 26

    MONTH: 04

    YEAR: 2007

    Concurrent daily cisplatin and extended-field radiation therapy for carcinoma of the cervix. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9111626

    Concurrent daily cisplatin and extended-field radiation therapy for carcinoma of the cervix. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Concurrent daily cisplatin and extended-field radiation therapy for carcinoma of the cervix. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Concurrent daily cisplatin and extended-field radiation therapy for carcinoma of the cervix.

    AFFILIATION: Departments of Radiology and Obstetrics and Gynecology, Graduate School of Medicine, Chiba University, Chiba, Japan.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Int J Gynecol Cancer

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Concurrent daily cisplatin and extended-field radiation therapy for carcinoma of the cervix Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News